Company Filing History:
Years Active: 2010
Title: The Innovations of Jin-In Kim
Introduction
Jin-In Kim is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target the central nervous system. His work is characterized by a focus on histamine receptors, which play a crucial role in various neurological disorders.
Latest Patents
Jin-In Kim holds a patent for a compound titled "N-benzoyl- and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists." This invention provides a compound of formula I and outlines its use for the treatment of central nervous system disorders related to or affected by the histamine-3 receptor. This patent highlights his innovative approach to addressing complex medical challenges.
Career Highlights
Throughout his career, Jin-In Kim has been associated with Wyeth, a prominent pharmaceutical company. His work at Wyeth has allowed him to collaborate with other talented professionals in the field, contributing to advancements in drug development and therapeutic solutions.
Collaborations
Jin-In Kim has worked alongside notable colleagues, including Derek Cecil Cole and Magda Asselin. Their collaborative efforts have fostered an environment of innovation and creativity, leading to impactful research and development in the pharmaceutical industry.
Conclusion
Jin-In Kim's contributions to the field of pharmaceuticals, particularly through his patent on histamine-3 antagonists, demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in the treatment of central nervous system disorders.